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Varicella zoster virus (VZV) open reading frame 61
(ORF61) is one of the four transcription regulated pro-
teins, which is homologous to herpes simplex virus 1
(HSV-1) ICP0 and can partially complement the function
of ICP0 in ICP0 deletion mutant HSV-1. Since ICP0 can
inhibit the innate immunity in many levels such as IRF3
and PML, here we investigate the role of ORF61 in helping
VZV evading IFN-b signal pathway. As the role of IFN-b
in VZV infection has little been reported previously, our
results demonstrated that IFN-b can limit VZV replication
in Mewo cells and VZV infection can suppress the secre-
tion of IFN-b in 293T cells and HeLa cells stimulated by
SeV or poly(I:C). In addition, we try to explore the mole-
cule mechanism by VZV to evade host innate immunity
system especially the IFN-b pathway. We found that
ORF61 can inhibit the activity of IFN-b promoter in 293T
cells by reporter assays in the presence of SeV or poly I:C.
The activity of ISRE (interferon-stimulated response ele-
ments, ISRE) promoter was also inhibited but not that of
NF-B promoter by ORF61, suggesting that ORF61 may
interfere with the activity of IRF3. Ultimately, our results
demonstrated that ORF61 degraded phosphorylation IRF3
via its E3 ubiquitin ligase activity. In one word, VZV
ORF61 could inhibit IFN-b pathway and may play a criti-
cal role in VZV pathogenesis.
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